These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24217945)

  • 1. 6-[18F]fluoro-L-DOPA uptake in the rat pancreas is dependent on the tracer metabolism.
    Kalliokoski T; Tuomela J; Haavisto L; Forsback S; Snellman A; Helin S; Grönroos TJ; Solin O; Haaparanta-Solin M
    Mol Imaging Biol; 2014 Jun; 16(3):403-11. PubMed ID: 24217945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of 6-[
    Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
    J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
    Ishiwata K; Shinoda M; Ishii S; Nozaki T; Senda M
    Nucl Med Biol; 1996 Apr; 23(3):295-301. PubMed ID: 8782240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
    Psylla M; Günther I; Antonini A; Vontobel P; Reist HW; Zollinger A; Leenders KL
    Brain Res; 1997 Aug; 767(1):45-54. PubMed ID: 9365014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-fluoroDOPA metabolism in rat striatum: time course of extracellular metabolites.
    DeJesus OT; Haaparanta M; Solin O; Nickles RJ
    Brain Res; 2000 Sep; 877(1):31-6. PubMed ID: 10980240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme inhibition of dopamine metabolism alters 6-[18F]FDOPA uptake in orthotopic pancreatic adenocarcinoma.
    Tuomela J; Forsback S; Haavisto L; Vahlberg T; Grönroos TJ; Solin O; Haaparanta-Solin M
    EJNMMI Res; 2013 Mar; 3(1):18. PubMed ID: 23497589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.
    Endres CJ; DeJesus OT; Uno H; Doudet DJ; Nickles JR; Holden JE
    Front Biosci; 2004 Jan; 9():505-12. PubMed ID: 14766386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
    Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
    Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.
    Li CT; Palotti M; Holden JE; Oh J; Okonkwo O; Christian BT; Bendlin BB; Buyan-Dent L; Harding SJ; Stone CK; DeJesus OT; Nickles RJ; Gallagher CL
    Synapse; 2014 Aug; 68(8):325-31. PubMed ID: 24710997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase inhibition increases the uptake of 11C-3-(3,4-dihydroxyphenyl)-L-alanine in the rat pancreas.
    Bergström M; Lu L; Marquez M; Moulder R; Jacobsson G; Ogren M; Eriksson B; Watanabe Y; Långström B
    Scand J Gastroenterol; 1996 Dec; 31(12):1216-22. PubMed ID: 8976015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data.
    Talbot JN; Kerrou K; Missoum F; Grahek D; Aide N; Lumbroso J; Montravers F
    Mol Imaging Biol; 2005; 7(4):257-61. PubMed ID: 16082495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
    Cumming P; Ase A; Diksic M; Harrison J; Jolly D; Kuwabara H; Laliberté C; Gjedde A
    Biochem Pharmacol; 1995 Sep; 50(7):943-6. PubMed ID: 7575677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA.
    Yee RE; Cheng DW; Huang SC; Namavari M; Satyamurthy N; Barrio JR
    Biochem Pharmacol; 2001 Nov; 62(10):1409-15. PubMed ID: 11709201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
    Melega WP; Luxen A; Perlmutter MM; Nissenson CH; Phelps ME; Barrio JR
    Biochem Pharmacol; 1990 Jun; 39(12):1853-60. PubMed ID: 2112915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
    Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
    Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET.
    Walker MD; Dinelle K; Kornelsen R; McCormick S; Mah C; Holden JE; Farrer MJ; Stoessl AJ; Sossi V
    J Cereb Blood Flow Metab; 2013 Jan; 33(1):59-66. PubMed ID: 22929441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
    Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment.
    van Beek AP; de Heide LJ; van Ginkel B; Slart RH; van der Horst-Schrivers AN; Boellaard R; de Vries EG; Noordzij W; Glaudemans AW
    Clin Nucl Med; 2017 Mar; 42(3):163-168. PubMed ID: 28005639
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.